Notes:
- Always prepare reagents freshly.
This application protocol describes the flow cytometric analysis of regulatory T cells (Tregs) after spleen dissociation from healthy C57BL/6 mice. Viable single cells from mouse spleens are easily obtained by tissue dissociation using gentleMACS® Technology. For downstream flow cytometric analysis of Tregs, a validated multicolor flow cytometry panel was designed using REAfinity™ Recombinant Antibodies and Viobility™ Fixable Dyes. In addition, an optimized gating strategy for the analysis of Tregs from mouse spleen is provided. This enables the efficient phenotyping of Tregs within the population of CD4+ T cells.
This protocol includes detailed instructions for preparing necessary reagents and materials and then carrying out each step.
Notes:
PEB buffer: Prepare a solution containing phosphate-buffered saline (PBS), pH 7.2, 0.5% bovine serum albumin (BSA), and 2 mM EDTA by diluting MACS® BSA Stock Solution (# 130-091-376) 1:20 with autoMACS® Rinsing Solution (# 130-091-222). Keep buffer cold (2–8 °C). Always use freshly prepared buffer. Do not use autoMACS Running Buffer or MACSQuant® Running Buffer as they contain a small amount of sodium azide that could affect the results.
Let the vials warm up to room temperature to avoid water condensation. Reconstitute one vial of lyophilized Viobility Fixable Dye by adding 100 μL anhydrous DMSO to the dye vial and mix until fully dissolved. Aliquot the solution and store at –20 °C under anhydrous conditions (desiccant) and protected from light for up to 1 month.
Notes:
Notes:
| Laser | Antibody specificity | Fluorochrome | Clone |
| Violet | CD4 | VioBlue® | REA604 |
| Viobility™ 405/520 Fixable Dye | |||
| Blue | FoxP3 | Vio® 515 | REA788 |
| CD357 (GITR) | PE | REA980 | |
| CD3ε | PE-Vio 615 | REA606 | |
| CD25 | PE-Vio 770 | REA568 | |
| Red | CD134 (OX40) | APC | REA625 |
* Exclusion channel containing lineage markers to exclude T cells (CD3ε), B cells (CD19), and NK cells (CD335 (NKp46)) from the analysis.
Notes:
Notes:
Notes:
Notes: